Hu, T.; Liu, Y.; Wu, J.; Hu, X.L.; Zhao, G.; Liang, B.; Wang, S.; Long, M.
Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy. J. Clin. Med. 2022, 11, 1607.
https://doi.org/10.3390/jcm11061607
AMA Style
Hu T, Liu Y, Wu J, Hu XL, Zhao G, Liang B, Wang S, Long M.
Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy. Journal of Clinical Medicine. 2022; 11(6):1607.
https://doi.org/10.3390/jcm11061607
Chicago/Turabian Style
Hu, Taobo, Yiqiang Liu, Jinbo Wu, Xuejiao Lina Hu, Guiyang Zhao, Baosheng Liang, Shu Wang, and Mengping Long.
2022. "Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy" Journal of Clinical Medicine 11, no. 6: 1607.
https://doi.org/10.3390/jcm11061607
APA Style
Hu, T., Liu, Y., Wu, J., Hu, X. L., Zhao, G., Liang, B., Wang, S., & Long, M.
(2022). Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy. Journal of Clinical Medicine, 11(6), 1607.
https://doi.org/10.3390/jcm11061607